KFDA publishes 2009 product license report

Published: 2010-08-06 07:00:00

Updated: 2010-08-06 07:00:00

The Korea Food and Drug Administration said on August 4 that it has published a report describing the license status of all pharmaceuticals last year.

The report contains a number data, including licenses of new drugs, orphan drugs, vaccine products and oriental medicines, according to KFDA of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK